Lates News

In the field of biomedicine, some domestically produced innovative drugs have shown effectiveness comparable to those of international pharmaceutical star products. In recent years, more and more international pharmaceutical companies have invested heavily in collaborating with Chinese pharmaceutical companies. Earlier this year, China's artificial intelligence model DeepSeek attracted worldwide attention with its low development cost and powerful performance. In fact, in the field of biotechnology, China is also experiencing a similar "DeepSeek moment". Chinese pharmaceutical companies are transitioning from the era of generic drugs to the era of innovative drugs and are attracting numerous international collaborations. The main form of collaboration is through licensing agreements, where the foreign party obtains the rights to develop, produce, and commercialize Chinese drugs or related technologies in markets outside of China. (CCTV Finance)